Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol. 2020 Jan;7(1):e28-e39. doi: 10.1016/S2352-3026(19)30157-7. Epub 2019 Oct 9.
Lancet Haematol. 2020.
PMID: 31606445
Clinical Trial.
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Casper J, Wolff D, Knauf W, Blau IW, Ruutu T, Volin L, Wandt H, Schäfer-Eckart K, Holowiecki J, Giebel S, Aschan J, Zander AR, Kröger N, Hilgendorf I, Baumgart J, Mylius HA, Pichlmeier U, Freund M.
Casper J, et al. Among authors: mylius ha.
J Clin Oncol. 2010 Jul 10;28(20):3344-51. doi: 10.1200/JCO.2009.23.3429. Epub 2010 May 24.
J Clin Oncol. 2010.
PMID: 20498405
Item in Clipboard
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
Casper J, Holowiecki J, Trenschel R, Wandt H, Schaefer-Eckart K, Ruutu T, Volin L, Einsele H, Stuhler G, Uharek L, Blau I, Bornhaeuser M, Zander AR, Larsson K, Markiewicz M, Giebel S, Kruzel T, Mylius HA, Baumgart J, Pichlmeier U, Freund M, Beelen DW.
Casper J, et al. Among authors: mylius ha.
Bone Marrow Transplant. 2012 Sep;47(9):1171-7. doi: 10.1038/bmt.2011.242. Epub 2011 Dec 12.
Bone Marrow Transplant. 2012.
PMID: 22158386
Clinical Trial.
Item in Clipboard
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Ruutu T, Volin L, Beelen DW, Trenschel R, Finke J, Schnitzler M, Holowiecki J, Giebel S, Markiewicz M, Uharek L, Blau IW, Kienast J, Stelljes M, Larsson K, Zander AR, Gramatzki M, Repp R, Einsele H, Stuhler G, Baumgart J, Mylius HA, Pichlmeier U, Freund M, Casper J.
Ruutu T, et al. Among authors: mylius ha.
Haematologica. 2011 Sep;96(9):1344-50. doi: 10.3324/haematol.2011.043810. Epub 2011 Jun 9.
Haematologica. 2011.
PMID: 21659356
Free PMC article.
Clinical Trial.
Item in Clipboard
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications.
Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME, Basara N, Fauser AA, Hertenstein B, Mylius HA, Baumgart J, Pichlmeier U, Hahn JR, Holler E.
Beelen DW, et al. Among authors: mylius ha.
Bone Marrow Transplant. 2005 Feb;35(3):233-41. doi: 10.1038/sj.bmt.1704784.
Bone Marrow Transplant. 2005.
PMID: 15592494
Clinical Trial.
Item in Clipboard
Treatment of active secondary progressive multiple sclerosis with treosulfan.
Wiendl H, Kieseier BC, Weissert R, Mylius HA, Pichlmeier U, Hartung HP, Melms A, Kuker W, Weller M.
Wiendl H, et al. Among authors: mylius ha.
J Neurol. 2007 Jul;254(7):884-9. doi: 10.1007/s00415-006-0459-6. Epub 2007 Apr 20.
J Neurol. 2007.
PMID: 17446994
Item in Clipboard
Treosulfan impedes the migration of immunocompetent cells.
Kopadze T, Dehmel T, Mylius HA, Hartung HP, Wiendl H, Kieseier BC.
Kopadze T, et al. Among authors: mylius ha.
J Neurol. 2007 Oct;254(10):1457-8. doi: 10.1007/s00415-007-0552-5. Epub 2007 Oct 15.
J Neurol. 2007.
PMID: 17932703
No abstract available.
Item in Clipboard
Cite
Cite